Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AK › Anchorage › NPI 1952348047
Hospital

Galen Hospital Alaska, INC.

Galen Hospital Alaska, INC. was paid $31.75M by Medicaid between Jan 2018 and Dec 2024, across 205 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.

33Billing provider infoGALEN HOSPITAL ALASKA, INC.
ANCHORAGE, AK 99508
33aNPI1952348047assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$31.75M
24GClaims590,557
24DCodes billed205
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Alaska

Rank by total paid#5 of 10
Median peer was paid$30.98M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201814,418$186K
201919,884$276K
202017,099$198K
202189,712$5.17M
2022153,297$9.57M
2023158,302$9.74M
2024incomplete137,845$6.61M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 31% 37,043 29,332 $9.70M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 27,072 23,003 $3.76M
74177 Computed tomography, abdomen and pelvis; with contrast material 8.3% 4,828 4,142 $2.64M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.1% 3,074 2,420 $1.31M
C1776 Joint device (implantable) 3.5% 361 254 $1.10M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.3% 17,055 13,586 $1.06M
70450 Computed tomography, head or brain; without contrast material 3.1% 4,612 4,009 $993K
G0378 Hospital observation service, per hour 2.5% 2,007 1,507 $808K
96361 Intravenous infusion, hydration; each additional hour 2.1% 14,698 11,523 $674K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.0% 1,351 1,155 $623K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.9% 10,021 8,850 $595K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.9% 20,256 16,030 $588K
193 more codes
71045 Radiologic examination, chest; single view 1.8% 11,366 $560K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 8,084 $489K
96375 Therapeutic injection; each additional sequential IV push 1.5% 10,556 $476K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1.3% 11,578 $404K
71046 Radiologic examination, chest; 2 views <1% 5,270 $300K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,601 $248K
72125 Computed tomography, cervical spine; without contrast material <1% 1,074 $226K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,760 $223K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,101 $214K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,284 $197K
80053 Comprehensive metabolic panel <1% 34,268 $189K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 150 $180K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,130 $172K
85027 <1% 39,130 $128K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,061 $127K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,243 $122K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,422 $121K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,644 $114K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,578 $110K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 711 $101K
70486 <1% 330 $101K
96376 <1% 3,358 $100K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,591 $97K
84484 <1% 14,623 $84K
73564 <1% 727 $83K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,236 $79K
83880 <1% 4,649 $79K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 784 $78K
93971 <1% 811 $77K
C1769 Guide wire <1% 491 $75K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,807 $73K
73030 <1% 1,239 $72K
73610 <1% 1,159 $70K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 380 $67K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,763 $65K
J7120 Ringers lactate infusion, up to 1000 cc <1% 17,515 $65K
J2060 Injection, lorazepam, 2 mg <1% 2,410 $56K
73630 <1% 948 $55K
84703 <1% 9,874 $52K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,901 $52K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,955 $49K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,959 $49K
83690 <1% 13,251 $48K
J2704 Injection, propofol, 10 mg <1% 4,387 $45K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 414 $45K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 162 $44K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,610 $44K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,068 $43K
J3535 Drug administered through a metered dose inhaler <1% 1,095 $41K
72100 <1% 760 $40K
10060 <1% 344 $39K
93975 <1% 194 $36K
J8540 Dexamethasone, oral, 0.25 mg <1% 2,166 $36K
84443 Thyroid stimulating hormone (TSH) <1% 3,923 $34K
70498 <1% 149 $34K
87040 <1% 5,368 $32K
J3490 Unclassified drugs <1% 3,699 $31K
73130 <1% 492 $31K
73110 <1% 539 $30K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 106 $29K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,036 $29K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,874 $28K
12001 <1% 250 $27K
73502 <1% 527 $27K
74018 <1% 380 $27K
82077 <1% 2,924 $26K
J7030 Infusion, normal saline solution , 1000 cc <1% 7,725 $26K
83605 <1% 4,143 $25K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,119 $24K
83735 <1% 6,829 $22K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,454 $22K
86141 <1% 2,719 $21K
80143 <1% 1,715 $19K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,796 $19K
81001 <1% 10,475 $19K
80179 <1% 1,604 $18K
90715 <1% 1,359 $18K
73080 <1% 228 $17K
70496 <1% 80 $16K
J1790 Injection, droperidol, up to 5 mg <1% 1,032 $16K
85379 <1% 2,749 $16K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 747 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 4,468 $16K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,278 $15K
73560 <1% 329 $15K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,164 $14K
J1650 Injection, enoxaparin sodium, 10 mg <1% 494 $14K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 782 $14K
76801 <1% 261 $13K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 161 $13K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,009 $12K
84702 <1% 1,011 $12K
76830 Ultrasound, transvaginal <1% 172 $11K
97116 <1% 548 $11K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 906 $11K
85610 <1% 4,820 $9K
82550 <1% 2,548 $8K
73590 <1% 162 $8K
72131 <1% 26 $8K
86850 <1% 1,707 $8K
87077 <1% 1,351 $8K
C9113 Injection, pantoprazole sodium, per vial <1% 861 $8K
80074 <1% 229 $8K
73562 <1% 90 $8K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 19 $7K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 30 $7K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 536 $7K
72040 <1% 91 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 133 $7K
81003 <1% 5,038 $7K
97535 Self-care/home management training, each 15 minutes <1% 348 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 422 $7K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 32 $7K
85730 <1% 2,458 $7K
87186 <1% 1,088 $6K
70491 <1% 15 $6K
76000 <1% 56 $6K
88307 <1% 21 $6K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,151 $6K
12002 <1% 42 $5K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 751 $5K
88342 <1% 126 $5K
85651 <1% 2,024 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 17 $5K
J7050 Infusion, normal saline solution, 250 cc <1% 2,579 $5K
J1630 Injection, haloperidol, up to 5 mg <1% 637 $5K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,333 $5K
73120 <1% 77 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 29 $4K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 31 $4K
87070 <1% 682 $4K
84439 <1% 711 $4K
86900 <1% 2,132 $3K
86901 <1% 2,132 $3K
12011 <1% 27 $3K
87205 <1% 1,145 $3K
97162 <1% 109 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 499 $3K
97163 <1% 80 $2K
71250 <1% 14 $2K
73140 <1% 42 $2K
86780 <1% 221 $2K
86592 <1% 506 $2K
71101 <1% 15 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 32 $1K
73090 <1% 28 $1K
J1953 Injection, levetiracetam, 10 mg <1% 71 $1K
70551 Magnetic resonance imaging, brain; without contrast material <1% 14 $1K
99152 <1% 104 $1K
77067 Screening mammography, bilateral, including computer-aided detection <1% 12 $982.47
81025 <1% 152 $971.65
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 63 $964.96
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 122 $909.92
80061 Lipid panel <1% 138 $852.92
87631 <1% 145 $728.17
J1940 Injection, furosemide, up to 20 mg <1% 118 $724.86
82728 <1% 97 $629.05
72170 <1% 22 $569.29
S0028 Injection, famotidine, 20 mg <1% 308 $561.63
97166 <1% 14 $473.87
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 564 $443.06
J2550 Injection, promethazine hcl, up to 50 mg <1% 276 $433.67
J1644 Injection, heparin sodium, per 1000 units <1% 209 $411.64
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 17 $368.14
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 142 $350.96
84100 <1% 111 $301.62
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 151 $288.79
J1171 Injection, hydromorphone, 0.1 mg <1% 191 $246.69
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 111 $218.36
82248 <1% 72 $215.86
J7999 Compounded drug, not otherwise classified <1% 80 $155.24
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 215 $142.17
87075 <1% 24 $129.29
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 376 $109.05
77063 Screening digital breast tomosynthesis, bilateral <1% 12 $101.53
83615 <1% 31 $96.64
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 153 $78.69
G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening <1% 631 $72.83
83540 <1% 14 $56.95
83930 <1% 16 $46.27
J3360 Injection, diazepam, up to 5 mg <1% 28 $29.12
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 86 $24.67
36415 Collection of venous blood by venipuncture <1% 6,927 $22.55
80076 <1% 17 $10.09
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,406 $8.92
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 1,337 $0.01
A9270 Non-covered item or service 0% 23,251 $0.00
80320 0% 3,874 $0.00
82553 0% 27 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 54 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 174 $0.00
J1815 Injection, insulin, per 5 units 0% 29 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 344 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKENNINGTON, LYNN (CFO)
Same official

Other billing entities under KENNINGTON, LYNN

Full network →
ProviderLocationPaid
Galen Hospital Alaska, INC.Anchorage, AK$25.11M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.